Eurofins Scientific SE(ERFSF)
USD --+0.00%
Reward40Moderate
Risk49Moderate
📊75%Data
ERFSF
+0.0 · +0.00%
USD · PINK
Eurofins Scientific SE | Healthcare
Value Trap
Market Cap:13.64Bn
ℹ️
Reward Rating
40
Moderate
Bottom 10% (model universe)
75% data coverage
ℹ️
Risk Rating
49
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on ERFSF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Eurofins Scientific SE?

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide.

ERFSF · Verdict

Moderate reward · moderate risk

ERFSF has limited near-term tailwinds — profitability and balance sheet weigh on the model output.

Based on 88% data coverage

ERFSF · Verdict

What’s working & what to watch

Watchouts 3

  • Profitability31/100

    7% net margin · 10% ROE

  • Balance sheet31/100

    Interest covered 4.9×

  • Growth33/100

    Rev +2.8% CAGR · earnings -8.0%

Model-based scoring. For information only — not financial advice.

What is Eurofins Scientific SE?

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, training, advisory, and labelling services; biopharma, and clinical diagnostics. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 13.64B, and a P/E ratio of 28.5x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (40)

The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap13.64B
P/E Ratio28.4888
Dividend Yield0.90%
52 Week High86.2
52 Week Low47.9935
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding176M
No. of Employees65,000
IndustryDiagnostics & Research
ExchangePINK
Beta0.96
CurrencyUSD